0000000000056219
AUTHOR
Javier Jiménez-candil
showing 6 related works from this author
Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: insights from the national…
2021
Abstract Aims Vitamin K antagonists (VKAs) are effective drugs reducing the risk for stroke in atrial fibrillation (AF), but the benefits derived from such therapy depend on the international normalized ratio (INR) maintenance in a narrow therapeutic range. Here, we aimed to determine independent variables driving poor anticoagulation control [defined as a time in therapeutic range (TTR) <65%] in a ‘real world’ national cohort of AF patients. Methods and results The SULTAN registry is a multicentre, prospective study, involving patients with non-valvular AF from 72 cardiology units expert in AF in Spain. At inclusion, all patients naïve for oral anticoagulation were started with VKAs…
Characteristics and Outcomes of Patients Hospitalized With Suspected Acute Coronary Syndrome in Whom the Diagnosis is not Confirmed
2018
Patients admitted with suspected acute coronary syndrome (ACS) in whom the diagnosis is not confirmed are poorly characterized. In a contemporary registry of consecutive patients hospitalized with suspected ACS as the primary diagnosis, we assessed characteristics on admission and in-hospital and 6-month mortality of patients discharged with other diagnoses and compared this subgroup with true ACS patients. Of 2557 patients included, 9.0% were discharged with a non-ACS diagnosis such as nonspecific chest pain, myopericarditis, stress cardiomyopathy, hemodynamic disturbances, heart failure, myocardial, pulmonary or valvular disease, or others. Compared with true ACS patients, those with othe…
Evidencias de la revascularización en el infarto agudo de miocardio
2011
Resumen La reperfusion precoz es la clave en el manejo de los pacientes con sindrome coronario agudo con elevacion del ST. Cuanto antes se consiga la reperfusion coronaria, mejor es el pronostico. Segun la evidencia cientifica, la intervencion coronaria percutanea primaria es superior a la fibrinolisis en cuanto a morbilidad y mortalidad y es el tratamiento de eleccion siempre que el retraso a la intervencion coronaria no vaya a superar los 90–120 min. Cuando el retraso a la reperfusion con intervencion coronaria percutanea va a ser largo (> 120 min), se recomienda iniciar el tratamiento con fibrinolisis. Por lo tanto, una limitacion muy importante para la adecuada implementacion de la inte…
Update on Ischemic Heart Disease and Critical Care Cardiology
2014
This article summarizes the main developments reported in 2013 on ischemic heart disease, together with the most important innovations in the management of acute cardiac patients. 3.792 JCR (2014) Q2, 34/123 Cardiac & cardiovascular systems UEM
Actualización en cardiopatía isquémica y cuidados críticos cardiológicos
2013
This article summarizes the main developments reported during the year 2012 concerning ischemic heart disease, together with the most relevant innovations in the management of acute cardiac patients. Full English text available from: www.revespcardiol.org/en.
Pronóstico y manejo del síndrome coronario agudo en España en 2012: estudio DIOCLES
2015
Resumen Introduccion y objetivos Conocer la mortalidad y el manejo actuales de los pacientes ingresados por sospecha de sindrome coronario agudo en Espana. El ultimo registro disponible (2004-2005) reporto una mortalidad hospitalaria del 5,7%. Metodos Se incluyo a los pacientes ingresados consecutivamente de enero a junio de 2012 en 44 hospitales seleccionados al azar. Se recogio la evolucion en el ingreso y los eventos a 6 meses. Resultados Se incluyo a 2.557 pacientes ingresados con sospecha de sindrome coronario agudo: 788 (30,8%) con elevacion del segmento ST, 1.602 (62,7%) sin elevacion del segmento ST y 167 (6,5%) con sindrome coronario agudo inclasificable. La mortalidad hospitalaria…